Clinical Trial Update: Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FluGlucoScan (fluorodeoxyglucose) in breast cancer, assessing correlation with histologic findings from sentinel node biopsies and axil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FluGlucoScan (fluorodeoxyglucose)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED